Credits: Canva
A newly developed “smart pill” that can confirm whether a medication has actually been swallowed could one day change how doctors track prescription use. Created by researchers at MIT along with partner institutions, the technology was described in a study published in Nature Communications. These electronic capsules are designed to send out a wireless signal once ingested and then safely dissolve inside the stomach over the course of about a week.
While the idea sounds straightforward, the implications are significant. Research shows that nearly half of Americans living with chronic illnesses do not take long-term medications exactly as prescribed. Below is what you need to know about how this smart pill works and why it matters.
In a development aimed at improving medication adherence, engineers at MIT have created a pill that can confirm when it has been swallowed. The reporting mechanism can be built into standard pill capsules and includes a biodegradable radio frequency antenna. After transmitting a signal to confirm ingestion, most of the pill’s components dissolve in the stomach. A tiny radio frequency chip then passes naturally through the digestive system and exits the body.
According to MIT News, researchers believe this technology could be particularly helpful for transplant recipients who rely on immunosuppressive drugs, as well as patients being treated long term for infections such as HIV or tuberculosis.
“The idea is to make sure this helps people receive the treatment they need so they can achieve the best possible health outcomes,” Giovanni Traverso, associate professor of medical engineering and senior author of the study, told MIT News.
Not taking medication as prescribed remains a major public health problem, contributing to hundreds of thousands of avoidable deaths and adding billions of dollars to healthcare costs every year. To address this, Traverso’s team has previously developed capsules that can stay in the digestive system for days or even weeks, releasing medicine at scheduled intervals. However, not every drug can be delivered in this way.
“We know that systems designed to stay in the body longer can improve adherence,” Traverso explained. “But for some medications, altering the pill isn’t an option. So the question is what else we can do to support patients and help healthcare providers ensure medications are actually being taken.”
In this latest study, the researchers shifted their focus toward better tracking of medication use. They turned to radio frequency technology, which is safe for humans and easy to detect from outside the body. This allowed them to design a capsule that sends a signal once it has been swallowed, giving doctors a clearer picture of whether patients are taking their medicine.
The capsule is designed to keep its signal blocked until it reaches the stomach. After ingestion, stomach fluids dissolve the outer coating, activating the radio frequency signal that confirms the pill has been swallowed. The remaining materials then break down safely inside the body.
To test the system, researchers conducted experiments in pigs, whose digestive systems are similar to those of humans. The study found that the capsules consistently transmitted signals after ingestion and dissolved without leaving behind harmful chemical residue, according to MIT News.
Looking ahead, researchers told the New York Post that they hope to develop a wearable device for humans that could receive the signal and automatically share the information with healthcare providers. Still, widespread use is not imminent. Despite encouraging early findings, the smart pills will need thorough testing in human trials to confirm both safety and effectiveness before they can receive approval.
Credit: Canva
Childhood obesity in India is expected to surge to a whopping 56 million by 2040 -- nearly a 20 percent rise from 2025, according to an alarming new global report released today by the World Obesity Federation.
The World Obesity Atlas 2026, released on World Obesity Day -- observed globally on March 4 -- revealed that of the 56 million, about 20 million children in the country will be obese, while the remaining will be overweight.
Globally, the number of children aged 5-19 years living with obesity or overweight is predicted to increase to 507 million by 2040 -- from 419 million in 2025.
Among children aged 5-9 years, 14.921 million were overweight or obese in 2025
In children aged 10-19 years, more than 26.402 million were overweight or obese.
India was among the top 10 countries -- second after China -- that accounted for over 200 million school-age children, aged 5-19 years, with high Body Mass Index (BMI).
Between 2010 and 2025, India had a 4.8 percent increase in the prevalence of high BMI and obesity among children aged 5-19 years.
"The increase in childhood obesity worldwide shows we have failed to take seriously a disease that affects one in five children," said Johanna Ralston, chief executive at the World Obesity Federation.
"Governments urgently need to step up prevention and management efforts for children living with overweight and obesity, and ensure that they receive the care they need," Ralston added.
By 2040, the report also projected a substantial increase in the risk of diseases among children aged 5-19 years due to a high BMI in India. This includes:
The key preventable risk factors in the country include:
Globally, the number of school-age children living with obesity now exceeds those living underweight.
Currently, more than one in five (20.7 per cent) 5-19 year-olds worldwide are living with obesity and overweight -- an increase from 14.6 per cent in 2010.
In 2025, about 177 million children aged 5-19 years were living with obesity. The number is expected to jump to 228 million in 2040.
By 2040, the Atlas also predicts that 227 million children aged 5-19 years will be living with obesity compared to 142 million living with underweight.
Notably, most of the world’s school-age children aged 5-19 living with obesity reside in the middle-income countries. By 2040, this is estimated to be as many as 169 million children.
The World Obesity Federation called for strong action to reverse current trends. These include imposing:
Credit: Canva
Tamil Nadu health authorities have ramped up surveillance efforts and implemented preventive and control measures to curb rising chickenpox cases in the state.
The Directorate of Public Health (DPH) and Preventive Medicine has instructed all health officers to intensify active and passive surveillance in all government and private health facilities, schools, colleges and hostels.
They were also directed to ensure that all suspected and confirmed cases are entered into the Integrated Disease Surveillance Programme (IDSP) line list with complete demographic and clinical details.
All medical officers across the state have further been asked to be alert to differentiate chickenpox from other rash illnesses such as measles, rubella, and hand, foot and mouth disease.
This comes weeks after doctors across Pune also warned against the exponential rise in chickenpox cases this winter.
Dr Shirish Kankariya, head of paediatrics at Apollo Hospital Swargate, said he had seen around 15 chickenpox patients in Jan alone, and the current season has brought a visible uptick in cases.
"Chickenpox cases have risen. We are also seeing infections in older children and adult family members, who never had the disease earlier," he told Times of India.
Dr Prateek Kataria, consultant pediatrician and neonatologist at Sahyadri Hospital also noted that out-patient departments (OPDs) have recently seen a large increase confirmed chickenpox cases this year.
He also told the publication: "We are seeing many children with chickenpox in the OPD even among those who have taken both doses of the vaccine. This is expected because the vaccine does not guarantee 100% protection, but vaccinated children usually develop milder illness and do not need hospitalization."
Chickenpox, caused by the varicella-zoster virus, is extremely contagious and spreads through respiratory droplets or direct contact with someone who is infected. In children, it often starts as a mild rash accompanied by fever, but it can spread quickly in crowded areas.
The virus can also be transmitted through coughing or sneezing, and it is most infectious a day or two before the rash appears and in the early days of the rash. In individuals with weak immunity, the dormant virus may reactivate later in life, causing shingles (herpes zoster).
Spotting chickenpox early means looking for general warning signs like fever, fatigue, headache, and loss of appetite, which usually appear one to two days before the rash.
The rash itself starts as tiny red spots that later form fluid-filled blisters and eventually scab over. Paying attention to these early symptoms, especially after known exposure, can help identify the infection sooner.
The first rash usually shows up as small red bumps on the face, chest, or back. These bumps quickly turn into blisters filled with fluid, which are contagious. Over a few days, the blisters break and crust over, forming scabs. It’s common to see spots, blisters, and scabs all at the same time, according to the CDC.
The Mayo Clinic explains that chickenpox progresses in three main stages:
Credit: Canva
A new study published in The Lancet Oncology journal today revealed that breast cancer continues to be the most common cancer among women worldwide, and predicted that the number of new cases of the deadly disease will reach more than 3.5 million globally in 2050 -- rising by a third from 2.3 million in 2023.
The Global Burden of Disease analysis with data from 204 countries revealed that despite advancements in breast cancer treatments, yearly deaths from the disease will rise by 44 percent -- from around 764,000 to 1.4 million.
While breast cancer disproportionately impacts countries with limited resources, maintaining a healthy lifestyle, including not smoking, getting sufficient physical activity, lowering red meat consumption, and having a healthy weight were found to prevent over a quarter of healthy years lost to illness and premature death.
“Breast cancer continues to take a profound toll on women’s lives and communities,” said lead author Kayleigh Bhangdia from the Institute for Health Metrics and Evaluation (IHME), University of Washington, US.
“While those in high-income countries typically benefit from screening and more timely diagnosis and comprehensive treatment strategies, the mounting burden of breast cancer is shifting to low- and lower middle-income countries where individuals often face later-stage diagnosis, more limited access to quality care, and higher death rates that are threatening to eclipse progress in women’s health,” Bhangdia added.
The study revealed that the rates of new cases remain highest in high-income countries (HICs), but are growing fastest in low-income countries (LICs).
Women in low- and lower-middle-income countries accounted for 27 percent (around 628,000) of new cases globally, exposing likely disparities in timely diagnosis and shortages of quality treatment, including radiotherapy machines, chemotherapy drugs, and pathology labs, and standard treatments.
In 2023, an estimated 2.3 million new breast cancers were diagnosed worldwide in women (with 73 percent or 1.67 million cases occurring in high- and upper-middle-income countries). Of these, 764,000 ended in deaths (with 39 percent or 300,000 deaths occurring in low- and lower-middle-income countries).
Further, the number of years of healthy life lost due to poor health and early death more than doubled from 11.7 million years in 1990 to 24 million years in 2023.
Women in low- and lower-middle-income countries also contribute to more than 45 percent of all the ill-health and early deaths from breast cancer globally (nearly 11 million years of healthy life lost).
The study reported a three-fold rise in pre-menopausal breast cancer in women aged 55 or older in 2023 -- compared to women aged 20-54 years.
However, rates of new cases have risen in women aged 20-54 years (up 29 percent) since 1990, with rates in older women remaining relatively unchanged.
In 2023, 28 percent of the global breast cancer burden (6.8 million years of healthy life lost to disability, illness, and early death) was linked to six potentially modifiable risk factors. These include:
Substantial progress has been made in reducing the global breast cancer burden linked to high alcohol use and tobacco between 1990 and 2023, which declined by 47 percent and 28 percent, respectively.
© 2024 Bennett, Coleman & Company Limited